Filtros : "Oliveira, Yara S." Limpar

Filtros



Refine with date range


  • Source: Journal of Molecular Structure. Unidade: IFSC

    Subjects: POLIMORFISMO, CRISTALOGRAFIA, PLANEJAMENTO DE FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      NOGUEIRA, Luciana de Pinho Pessoa et al. Crystalline structure of the marketed form of Rifampicin: a case of conformational and charge transfer polymorphism. Journal of Molecular Structure, v. 1155, p. 260-266, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.molstruc.2017.10.083. Acesso em: 03 jun. 2024.
    • APA

      Nogueira, L. de P. P., Oliveira, Y. S., Fonseca, J. C., Costa, W. S., Raffin, F. N., Ellena, J., & Ayala, A. P. (2018). Crystalline structure of the marketed form of Rifampicin: a case of conformational and charge transfer polymorphism. Journal of Molecular Structure, 1155, 260-266. doi:10.1016/j.molstruc.2017.10.083
    • NLM

      Nogueira L de PP, Oliveira YS, Fonseca JC, Costa WS, Raffin FN, Ellena J, Ayala AP. Crystalline structure of the marketed form of Rifampicin: a case of conformational and charge transfer polymorphism [Internet]. Journal of Molecular Structure. 2018 ; 1155 260-266.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.molstruc.2017.10.083
    • Vancouver

      Nogueira L de PP, Oliveira YS, Fonseca JC, Costa WS, Raffin FN, Ellena J, Ayala AP. Crystalline structure of the marketed form of Rifampicin: a case of conformational and charge transfer polymorphism [Internet]. Journal of Molecular Structure. 2018 ; 1155 260-266.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.molstruc.2017.10.083
  • Source: Journal of Pharmaceutical Sciences. Unidade: IFSC

    Subjects: PLANEJAMENTO DE FÁRMACOS, FILARIOSE, ESPECTROSCOPIA RAMAN

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HONORATO, Sara B. et al. On the thermal stability of the diethylcarbamazine-fortified table salt used in the control of lymphatic filariasis. Journal of Pharmaceutical Sciences, v. 105, n. 8, p. 2437-2443, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2016.06.003. Acesso em: 03 jun. 2024.
    • APA

      Honorato, S. B., Silva, C. C. P., Oliveira, Y. S., Mendonça, J. S., Boechat, N., Ellena, J., & Ayala, A. P. (2016). On the thermal stability of the diethylcarbamazine-fortified table salt used in the control of lymphatic filariasis. Journal of Pharmaceutical Sciences, 105( 8), 2437-2443. doi:10.1016/j.xphs.2016.06.003
    • NLM

      Honorato SB, Silva CCP, Oliveira YS, Mendonça JS, Boechat N, Ellena J, Ayala AP. On the thermal stability of the diethylcarbamazine-fortified table salt used in the control of lymphatic filariasis [Internet]. Journal of Pharmaceutical Sciences. 2016 ; 105( 8): 2437-2443.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.xphs.2016.06.003
    • Vancouver

      Honorato SB, Silva CCP, Oliveira YS, Mendonça JS, Boechat N, Ellena J, Ayala AP. On the thermal stability of the diethylcarbamazine-fortified table salt used in the control of lymphatic filariasis [Internet]. Journal of Pharmaceutical Sciences. 2016 ; 105( 8): 2437-2443.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.xphs.2016.06.003

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024